Signaling Pathways - PRMT - Insulin and Insulin-like Receptors - ERK - Raf
清除全部
- B6182 GSK591Target: PRMTSummary: PRMT5抑制剂
- A8716 LY3009120Target: RafSummary: Pan-RAF和RAF二聚体抑制剂
- B1106 VRT752271Target: ERKSummary: ERK1/ERK2 inhibitor
- B1174 LGX818中文名: 康奈非尼Target: RafSummary: RAF抑制剂
- B1407 Dabrafenib (GSK2118436)3 Citation中文名: 达拉菲尼Target: RafSummary: BRAF(V600)突变抑制剂
- A8616 A-674563Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSKSummary: Akt1 / PKA / CDK2的强效选择性抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A8313 RAF265Target: Raf|VEGFRSummary: 多细胞激酶抑制剂
- A8304 FR 180204Target: ERKSummary: ERK inhibitor
- A5801 BIX 02189Target: MEK|ERKSummary: MEK5抑制剂